CAR T-cells for T-cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) has a dismal prognosis in case of relapsed or refractory disease. Contrary to B-ALL, few immunotherapies are available for T-ALL. Use of autologous CAR T-cells is challenging due to shared antigen between leukemic and normal T-cells responsible for fratric...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2024-06-01
|
| Sarja: | EJC Paediatric Oncology |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2772610X24000096 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|